What does an Epstein Barr Virus (EBV) Immunoglobulin G (IgG) result of 501 indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpretation of EBV IgG Result of 501

An EBV IgG value of 501 (units typically U/mL or arbitrary units depending on the laboratory) indicates past Epstein-Barr virus infection, as elevated IgG antibodies persist for life after primary infection and do not indicate acute or current disease. 1, 2

Understanding the Result

  • IgG antibodies to EBV viral capsid antigen (VCA) develop during acute infection and remain elevated permanently, making them markers of past exposure rather than active disease 2, 3
  • Over 90% of normal adults have detectable IgG antibodies to VCA from past infection, so this finding alone is expected in the general population 2
  • The presence of VCA IgG without additional context (IgM status, EBNA status) cannot distinguish between recent and remote infection 4

Critical Next Steps for Complete Interpretation

To properly interpret this result and determine infection timing, you must evaluate:

  • VCA IgM status: Positive IgM indicates acute or recent infection (within weeks to months), while negative IgM suggests remote infection 1, 2
  • EBNA antibodies: The presence of EBNA antibodies indicates infection occurred more than 6 weeks prior, making EBV unlikely as the cause of current symptoms 1, 2
  • Clinical context: Current symptoms suggestive of infectious mononucleosis versus asymptomatic screening 2

Diagnostic Algorithm Based on Additional Testing

If VCA IgG positive + VCA IgM positive + EBNA negative:

  • This indicates primary acute EBV infection occurring within the past 1-2 months 1, 2, 3

If VCA IgG positive + VCA IgM negative + EBNA positive:

  • This indicates past infection (>2-3 months ago), and EBV is not the cause of current acute symptoms 1, 2

If VCA IgG positive + VCA IgM negative + EBNA negative:

  • This pattern is ambiguous and requires IgG avidity testing to distinguish early acute infection from past infection with loss of EBNA response 4, 5
  • Low avidity IgG suggests acute infection within 10-30 days 5
  • High avidity IgG (>0.5) indicates past infection 5

When Elevated IgG Levels Suggest Active Disease

Markedly elevated VCA IgG titers (≥1:640) combined with elevated EA IgG (≥1:160) may indicate Chronic Active EBV Infection (CAEBV), particularly when accompanied by:

  • Persistent infectious mononucleosis-like symptoms 6, 1
  • Positive IgA antibodies to VCA and/or EA 6, 1
  • EBV DNA levels >10^2.5 copies/mg DNA in peripheral blood mononuclear cells 1

Common Pitfalls to Avoid

  • Do not interpret isolated VCA IgG results without VCA IgM and EBNA testing, as this provides incomplete information about infection timing 1, 2, 4
  • Do not assume elevated IgG indicates active infection in immunocompetent patients—quantitative EBV viral load testing by nucleic acid amplification is required for suspected active disease in immunocompromised patients 1, 2
  • Do not order repeat IgG testing for monitoring in immunocompetent patients, as IgG remains elevated for life and does not reflect disease activity 2
  • In immunocompromised patients (transplant recipients, HIV-infected individuals), serology is unreliable and quantitative EBV DNA viral load testing should be used instead 1, 2

References

Guideline

EBV Testing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosing Infectious Mononucleosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis of Epstein-Barr virus-related diseases.

Scandinavian journal of infectious diseases. Supplementum, 1996

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.